NEW YORK, May 27 - Stichting Netherlands Bioinformatics Center in Amersfoort, Netherlands, has licensed the Rosetta Resolver gene expression data analysis system, Rosetta Biosoftware and the center jointly announced today.
Under the license, Resolver will be made available to the Dutch research community through the Netherlands Bioinformatics Center (NBIC) BioASP portal.
BioASP works on an Application Service Provider model, under which it provides support, infrastructure, and expertise to users in about 10 academic research labs. The government-supported initiative is aimed at building a genomics infrastructure in the country. In addition to Resolver, the BioASP plans to include other gene expression software as well as services including storage and other algorithms.
Rosetta Biosoftare, of
Other licensees of Resolver have included The Genomics Institute of the Novartis Research Foundation, Japan's National Institute of Radiological Sciences, Abbott Laboratories, Genencor International, Aventis Pharmaceuticals, COR Therapeutics, GlaxoSmithKline, Biogen, Bristol-Myers Squibb, the University of Washington, Immunex, Monsanto, the Harvard Center for Genomics Research, and Paradigm Genetics.